Semba CP - Search Results

1

Treatment of occluded central venous catheters with alteplase: results in 1,064 patients.

Semba CP, Deitcher SR, Li X, Resnansky L, Tu T, McCluskey ER; Cardiovascular thrombolytic to Open Occluded Lines Investigators. Semba CP, et al. J Vasc Interv Radiol. 2002 Dec;13(12):1199-205. doi: 10.1016/s1051-0443(07)61965-4. J Vasc Interv Radiol. 2002. PMID: 12471182 Clinical Trial.

2

Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial.

Deitcher SR, Fesen MR, Kiproff PM, Hill PA, Li X, McCluskey ER, Semba CP; Cardiovascular Thrombolytic to Open Occluded Lines-2 Investigators. Deitcher SR, et al. Among authors: semba cp. J Clin Oncol. 2002 Jan 1;20(1):317-24. doi: 10.1200/JCO.2002.20.1.317. J Clin Oncol. 2002. PMID: 11773185 Clinical Trial.

3

Recombinant tissue plasminogen activator (alteplase) for restoration of function to occluded central venous catheters in pediatric patients.

Shen V, Li X, Murdock M, Resnansky L, McCluskey ER, Semba CP; COOL Investigators. Shen V, et al. Among authors: semba cp. J Pediatr Hematol Oncol. 2003 Jan;25(1):38-45. doi: 10.1097/00043426-200301000-00009. J Pediatr Hematol Oncol. 2003. PMID: 12544772 Clinical Trial.

4

Alteplase for treatment of occluded peripherally inserted central catheters: safety and efficacy in 240 patients.

Ng R, Li X, Tu T, Semba CP. Ng R, et al. Among authors: semba cp. J Vasc Interv Radiol. 2004 Jan;15(1 Pt 1):45-9. doi: 10.1097/01.rvi.000099538.29957.f7. J Vasc Interv Radiol. 2004. PMID: 14709686 Clinical Trial.

5

Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study).

Blaney M, Shen V, Kerner JA, Jacobs BR, Gray S, Armfield J, Semba CP; CAPS Investigators. Blaney M, et al. Among authors: semba cp. J Vasc Interv Radiol. 2006 Nov;17(11 Pt 1):1745-51. doi: 10.1097/01.RVI.0000241542.71063.83. J Vasc Interv Radiol. 2006. PMID: 17142704 Clinical Trial.

6

Alteplase and tenecteplase: applications in the peripheral circulation.

Semba CP, Sugimoto K, Razavi MK; Society of Cardiovascular and Interventional Radiology (SCVIR). Semba CP, et al. Tech Vasc Interv Radiol. 2001 Jun;4(2):99-106. doi: 10.1016/s1089-2516(01)90003-4. Tech Vasc Interv Radiol. 2001. PMID: 11981795 Review.

7

Alteplase as a catheter locking solution: in vitro evaluation of biochemical stability and antimicrobial properties.

Weck S, Cheung S, Hiraoka-Sutow M, Patapoff T, Semba CP. Weck S, et al. Among authors: semba cp. J Vasc Interv Radiol. 2005 Mar;16(3):379-83. doi: 10.1097/01.RVI.0000148154.30967.27. J Vasc Interv Radiol. 2005. PMID: 15758134

8

Alteplase stability and bioactivity after low-power ultrasonic energy delivery with the OmniSonics resolution system.

Smikahl J, Yeung D, Wang S, Semba CP. Smikahl J, et al. Among authors: semba cp. J Vasc Interv Radiol. 2005 Mar;16(3):385-9. doi: 10.1097/01.RVI.0000147066.97599.87. J Vasc Interv Radiol. 2005. PMID: 15758135

9

Alteplase: stability and bioactivity after dilution in normal saline solution.

Semba CP, Weck S, Patapoff T. Semba CP, et al. J Vasc Interv Radiol. 2003 Jan;14(1):99-102. doi: 10.1097/01.rvi.0000052297.26939.05. J Vasc Interv Radiol. 2003. PMID: 12525593

10

Tenecteplase: stability and bioactivity of thawed or diluted solutions used in peripheral thrombolysis.

Semba CP, Weck S, Razavi MK, Tuomi L, Patapoff T. Semba CP, et al. J Vasc Interv Radiol. 2003 Apr;14(4):475-9. doi: 10.1097/01.rvi.0000064843.87207.f7. J Vasc Interv Radiol. 2003. PMID: 12682204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters